CTOs on the Move


 
Schedule your appointment with a local hearing healthcare professional. See available times and providers, book online with EarQ, and start hearing better!
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.earq.com
  • 701, Erie Boulevard West
    Syracuse, NY USA 13204
  • Phone: 800.338.0705

Executives

Name Title Contact Details

Similar Companies

Add-A-Tech Inc

Add-A-Tech Inc is a Wayne, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Darin M. Camarena Health Center

Darin M. Camarena Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Madera, CA. To find more information about Darin M. Camarena Health Center, please visit www.camarenahealth.org

Universal Health Services

Universal Health Services, Inc. (NYSE: UHS) is a Fortune 500 company based in King of Prussia, Pennsylvania. UHS owns and operates acute care hospitals, behavioral health centers, and ambulatory surgery centers in 37 states, Puerto Rico and the U.S. Virgin Islands. Universal Health Services, Inc. (UHS) is one of the largest hospital management companies in the United States. Through its subsidiaries, UHS operates 226 acute care hospitals, behavioral health facilities and ambulatory surgery centers. The company employs more than 60,000 people.

Ccs

Ccs is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.